{"disease":{"id":"pityriasis-rubra-pilaris","name":"pityriasis rubra pilaris"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03975153","title":"Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Oregon Health and Science University","has_results":true},{"nct_id":"NCT07497620","title":"Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06444399","title":"Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03342573","title":"Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03485976","title":"Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Oregon Health and Science University","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}